Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
Clinical trial NCT01585688 · TERMINATED
Trial details
- NCT number
- NCT01585688
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2016-11-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.